Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORESIGHT: Olanzapine vs Aprepitant in CINV
NCT04075955Phase 3Completed
- Sponsor
- Centre de recherche Charles-Le Moyne
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Centre de recherche Charles-Le Moyne. Started Apr 2019; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04075955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04075955.